Catalog Advanced Search
-
Contains 0 Component(s), Includes Credits
CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- State the role of both prescription and illicit opioids within osteopathic care.
- Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
- Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
- Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
- Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
- Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.
- Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
- Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
- Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
- In-person (September 20 - 22): OMED, San Antonio, TX
- Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.
Annette T. Carron, DO, MACOI
Medical Director
Seasons Hospice Michigan
Medical Director, Seasons Hospice Michigan
Attending Physician Geriatrics and Palliative Care, Henry Ford Macomb Hospital
Clinical Professor of Medicine
Michigan State University College of Osteopathic Medicine Clinton Township, MIDr. Annette T. Carron, DO, FACOI has no disclosures.
Dr. Jeff Cashman DO, MS, FACOFP
American College of Osteopathic Family Physicians
Dr. Jeff Cashman DO, MS, FACOFP earned his Bachelor of Science degree in Industrial Engineering from Clemson University (2001), a master’s degree in Epidemiology from the Medical University of South Carolina (2006) and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine-Georgia Campus (2010). He completed his family medicine residency at AnMed Health Family medicine residency in Anderson, SC in 2013.
Dr. Cashman currently serves as the Associate Dean for Pre-Clinical Medical Education at the Edward Via College of Osteopathic Medicine – Carolinas Campus; previously serving as the Associate Dean of OMS-IV and Graduate Medical Education and Discipline Chair of Family Medicine. As well, he serves as a preceptor at the Spartanburg Regional Family Medicine Residency and is the team physician for Spartanburg High School. Prior to starting at VCOM-Carolinas, Dr. Cashman practiced inpatient and outpatient medicine at Mary Black Hospital in Spartanburg, SC.
Dr. Cashman serves as the Speaker of the House of Delegates for the South Carolina Medical Association and was the first Osteopathic President of the Spartanburg County Medical Society. He is involved with the South Carolina Osteopathic Medical Society and previously chaired the SCMA Bioethics Committee and SC Ethics Pandemic Task Force. He is the Leadership Director for VCOM-Carolinas’ HRSA funded Primary Care Champions Fellowship and was named to the SC Rural Physician Board.
Jeff Cashman DO, MS, FACOFP has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 4 Product(s)
CME Available: 6.0 AOA Category 1-A credits 6.0 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- State the role of both prescription and illicit opioids within osteopathic care.
- Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
- Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
- Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
- Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
- Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.
- Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
- Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
- Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
- In-person (September 20 - 22): OMED, San Antonio, TX
- Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.0 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 0 Component(s), Includes Credits
CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- State the role of both prescription and illicit opioids within osteopathic care.
- Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
- Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
- Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
- Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
- Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.
- Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
- Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
- Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
- In-person (September 20 - 22): OMED, San Antonio, TX
- Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.
Dr. Jeff Cashman DO, MS, FACOFP
American College of Osteopathic Family Physicians
Dr. Jeff Cashman DO, MS, FACOFP earned his Bachelor of Science degree in Industrial Engineering from Clemson University (2001), a master’s degree in Epidemiology from the Medical University of South Carolina (2006) and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine-Georgia Campus (2010). He completed his family medicine residency at AnMed Health Family medicine residency in Anderson, SC in 2013.
Dr. Cashman currently serves as the Associate Dean for Pre-Clinical Medical Education at the Edward Via College of Osteopathic Medicine – Carolinas Campus; previously serving as the Associate Dean of OMS-IV and Graduate Medical Education and Discipline Chair of Family Medicine. As well, he serves as a preceptor at the Spartanburg Regional Family Medicine Residency and is the team physician for Spartanburg High School. Prior to starting at VCOM-Carolinas, Dr. Cashman practiced inpatient and outpatient medicine at Mary Black Hospital in Spartanburg, SC.
Dr. Cashman serves as the Speaker of the House of Delegates for the South Carolina Medical Association and was the first Osteopathic President of the Spartanburg County Medical Society. He is involved with the South Carolina Osteopathic Medical Society and previously chaired the SCMA Bioethics Committee and SC Ethics Pandemic Task Force. He is the Leadership Director for VCOM-Carolinas’ HRSA funded Primary Care Champions Fellowship and was named to the SC Rural Physician Board.
Jeff Cashman DO, MS, FACOFP has no disclosures.
Dr. Kathleen M. Farrell, DO
American College of Osteopathic Family Physicians
Kathleen M. Farrell, DO, is a graduate of the Arizona College of Osteopathic Medicine. She is certified in family medicine with the American Osteopathic Board of Family Physicians and in addiction medicine with American Osteopathic Academy of Addiction Medicine. Before obtaining her osteopathic medical degree, she earned her bachelor's degree in social welfare at the University of Washington. She is currently working for the VA in the opioid safety clinic in the pain department at American Lakes in Tacoma, Washington.
She got her "XF" soon after she got out of residency and when she started a practice with a Valley Family Health Care, a federally qualified health center in New Plymouth, Idaho. While in Idaho, she founded the Idaho Osteopathic Physicians Association and started using buprenorphine to treat her patients on illicit opioids. She continued this work when she moved to Port Angeles, Washington, to work at the Jamestown Family Health Clinic in Sequim, Washington, run by the Jamestown S'kallam Tribe. She realized that buprenorphine was not only successful in treating patients on illicit opioids, but buprenorphine could be used successfully to replace full agonist opioids in patients being treated for pain.
Her interest in working with patients on opioids continued when she became the medical director for the VA clinic in Port Angeles. When the VA started a program that allowed primary care physicians to use buprenorphine for veterans on opioids, she transferred to Tacoma. A native of the Northwest, she enjoys hiking and camping. She is a member of the Sunset Rotary Club where she has worked on "Masking the Homeless," promoting blood drives and other projects that support her community. She also enjoys Argentinian tango, which has been a COVID-challenged sport.
Dr. Kathleen M. Farrell, DO has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 4 Component(s), Includes Credits
CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- State the role of both prescription and illicit opioids within osteopathic care.
- Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
- Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
- Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
- Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
- Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.
- Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
- Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
- Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
- In-person (September 20 - 22): OMED, San Antonio, TX
- Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 4 Component(s), Includes Credits
CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- State the role of both prescription and illicit opioids within osteopathic care.
- Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
- Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
- Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
- Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
- Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.
There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.
- Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
- Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
- Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
- In-person (September 20 - 22): OMED, San Antonio, TX
- Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DE
Dr. Robert N. Agnello, DO, FACOFP
American College of Osteopathic Family Physicians
Robert N. Agnello, DO, FACOFP is assistant professor of family medicine and osteopathic manipulative medicine at CUSOM. He has been adjunct faculty since the inception of CUSOM in 2013 assisting the OMM department. Dr. Agnello is board-certified in family medicine since 2001 via Warren Hospital in Phillipsburg, NJ and added a CAQ in pain medicine in 2017. He has worked at the Womack Army Medical Center in family medicine since 2010 and interdisciplinary pain medicine since 2014. Clinical interest is in pain management via integrative osteopathic medicine. The focus is to develop osteopathic plans of medical care through using a combination of integrative medicine strategy. Research interest includes complementary care modalities and the impact techniques such as osteopathic manipulation, auricular acupuncture and functional medicine have on pain.
Dr. Robert N. Agnello, DO, FACOFP has no disclosures.
Dr. Kathleen M. Farrell, DO
American College of Osteopathic Family Physicians
Kathleen M. Farrell, DO, is a graduate of the Arizona College of Osteopathic Medicine. She is certified in family medicine with the American Osteopathic Board of Family Physicians and in addiction medicine with American Osteopathic Academy of Addiction Medicine. Before obtaining her osteopathic medical degree, she earned her bachelor's degree in social welfare at the University of Washington. She is currently working for the VA in the opioid safety clinic in the pain department at American Lakes in Tacoma, Washington.
She got her "XF" soon after she got out of residency and when she started a practice with a Valley Family Health Care, a federally qualified health center in New Plymouth, Idaho. While in Idaho, she founded the Idaho Osteopathic Physicians Association and started using buprenorphine to treat her patients on illicit opioids. She continued this work when she moved to Port Angeles, Washington, to work at the Jamestown Family Health Clinic in Sequim, Washington, run by the Jamestown S'kallam Tribe. She realized that buprenorphine was not only successful in treating patients on illicit opioids, but buprenorphine could be used successfully to replace full agonist opioids in patients being treated for pain.
Her interest in working with patients on opioids continued when she became the medical director for the VA clinic in Port Angeles. When the VA started a program that allowed primary care physicians to use buprenorphine for veterans on opioids, she transferred to Tacoma. A native of the Northwest, she enjoys hiking and camping. She is a member of the Sunset Rotary Club where she has worked on "Masking the Homeless," promoting blood drives and other projects that support her community. She also enjoys Argentinian tango, which has been a COVID-challenged sport.
Dr. Kathleen M. Farrell, DO has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 14 Product(s)
Note: This education is not intended to replace or supplant endocrinology board certification. Instead, this is a supplemental educational program for physicians who treat patients with diabetes. It is always recommended that primary management of diabetes is performed by the patient’s board-certified endocrinologist. The American College of Osteopathic Family Physicians (ACOFP), in collaboration with the Endocrine Society, has created a certificate program exploring the many facets of diabetes care and management. Developed through the efforts of endocrinologists and family physicians, this 12-part course encompasses both the clinical aspects of diabetes care as well as the supportive social pieces. This course features 12 modules, each with a pre- and post-test, as well as a final exam to test your knowledge and competency at the end of the course. The entire course, including the final exam, offers 15.00 AOA Category 1-A CME, 15.00 AMA PRA Category 1 credits, and 15.00 ABIM MOC points for successful course completion. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam. Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024. Learning Objectives Upon the successful completion of this 12-part course, learners will: • Describe the spectrum of diabetes and considerations in special populations to provide personalized care. • Identify patient-centered approaches to support psychosocial concerns and social determinants of health in patients with diabetes. • Recognize approaches to patient engagement for successful approaches to prevention of progression of prediabetes to type 2 diabetes. • Apply medical therapy options of insulin and non-insulin treatments to managing patient cases. • Compare innovative approaches to care delivery with new technology and therapeutic options.
Note: This education is not intended to replace or supplant endocrinology board certification. Instead, this is a supplemental educational program for physicians who treat patients with diabetes. It is always recommended that primary management of diabetes is performed by the patient’s board-certified endocrinologist.
The American College of Osteopathic Internists (ACOI) has created a certificate program exploring the many facets of diabetes care and management. Developed through the efforts of endocrinologists and family physicians, this 12-part course encompasses both the clinical aspects of diabetes care as well as the supportive social pieces.
This course features 12 modules, each with a pre- and post-test, as well as a final exam to test your knowledge and competency at the end of the course. The entire course, including the final exam, offers 15.00 AOA Category 1-A CME, 15.00 AMA PRA Category 1 credits, and 15.00 ABIM MOC points for successful course completion. Each module is expected to take around 75 minutes to complete for a total of approximately 15 contact hours plus the final exam.
Note that you have one year from the date of access to complete the course content and final exam, through 12/31/2024. If you do not complete the material and exam within that year, you will have to repurchase the course. Once the content has been completed, you will retain access to the course through its expiration on 12/31/2024.
Learning Objectives
Upon the successful completion of this 12-part course, learners will:- Describe the spectrum of diabetes and considerations in special populations to provide personalized care.
- Identify patient-centered approaches to support psychosocial concerns and social determinants of health in patients with diabetes.
- Recognize approaches to patient engagement for successful approaches to prevention of progression of prediabetes to type 2 diabetes.
- Apply medical therapy options of insulin and non-insulin treatments to managing patient cases.
- Compare innovative approaches to care delivery with new technology and therapeutic options.
Audience
The target audience for the certificate program is physicians interested in expanding their approaches to diabetes care and management. This course will also be of interest to those responsible for the care of patients with diabetes, primarily nurse practitioners, registered nurses, physician assistants, and pharmacists.Prices:
- Non-Member: $550.00
- Member: $450.00
- Resident/Fellow: $350.00
- Student: FREE
Statement of Independence
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
This program is sponsored by ACOFP for educational purposes only. The material presented is not intended to represent the sole or best medical interventions for the discussed diagnoses, but rather is intended to present the opinions of the authors or presenters that may be helpful to other practitioners. Attendees participating in this medical education program do so with the full knowledge that they waive any claim they may have against ACOFP for reliance on any information presented during these educational activities.
Disclaimers
The American College of Osteopathic Family Physicians (ACOFP) online education is an educational resource and as such does not define a standard of care, nor is it intended to dictate an exclusive course of treatment or procedure to be followed. It presents methods and techniques of clinical practice that are acceptable and used by recognized authorities, for consideration by licensed physicians and healthcare providers to incorporate into their practice. Variations of practice, taking into account the needs of the individual patient, resources, and limitation unique to the institution or type of practice, may be appropriate.
The statements and opinions expressed within this educational program are those of the faculty and not necessarily those of the ACOFP. The ACOFP disclaims any responsibility and/or liability for such information.
Faculty Disclosure Policies
It is the policy of the American College of Osteopathic Family Physicians (ACOFP) to ensure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any ACOFP sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker's outside interests may reflect a possible bias in either the exposition or the conclusions presented.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported relevant financial relationships: Kevin T. Miller, DO: Advisory Board - Astra Zeneca; Research Funding - Abbott, Pendulum. Elizabeth M. Venditti, PhD: Advisory Board - PeopleOne Health. Jay H. Shubrook, DO, FAAFP, FACOFP: Advisory Board - Novo Nordisk, Bayer, Eli Lilly. John L. Leahy, MD: Advisory Board - Merck & Co, Hillbloom Foundation. Lawrence Blonde, MD, FACP, MACE: Consultant - Corcept Therapeutics, Gilead Sciences, Janssen Pharmaceuticals, Lyndra Therapeutics, Merck, Novo Nordisk, Salix Pharmaceuticals, Sanofi. Eden M. Miller, DO: Advisory Board - Abbott, Lilly, Novo Nordisk, Boehringer Ingelheim, Merck, Bayer, Pendulum. Anne L. Peters, MD: Advisory Board - Abbott, Astra Zeneca, Lilly, Medscape, Novo Nodisk, Zealand, Vertex. Leonard R. Bertheau, DO: Speaker - Medtronic. Davida F. Kruger, MSN, APN-BC, BC-ADM: Speaker - Novo Nordisk, Eli Lilly, Abbott, Dexcom, Xeris, Astra Zeneca, Sanofi; Advisor - Novo Nordisk, Eli Lilly, Abbott, Sanofi; Stock Options - Pendulum; Research Funding - Novo Nordisk, Dexcom, Abbott. Mark E. Molitch, MD: Research Funding - Bayer, Novartis; Consultant - Janssen, Merck, Pfizer.
The following faculty reported no relevant financial relationships: Kim Pfotenhauer, DO; Robert S. Gotfried, DO, FAAFP
The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff associated with the development of this CME activity reported no relevant financial relationships.
The American College of Osteopathic Family Physicians (ACOFP) and the Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.
Kim Pfotenhauer, DO
Michigan State University College of Osteopathic Medicine
East Lansing, MI
• No disclosures
Kevin T. Miller, DO
Diabetes and Obesity Care
Bend, OR
Disclosures:
• Advisory Board; Astra Zeneca Research Funding: Abbott; Pendulum
Elizabeth M. Venditti, PhD
University of Pittsburgh School of Medicine
Pittsburgh, PA
Disclosures:
• Advisory Board: PeopleOne Health
Jay H. Shubrook, DO, FAAFP, FACOFP
Touro University
Vallejo, CA
Disclosures:
• Advisory Board: Novo Nordisk; Bayer; Eli Lilly
John L. Leahy, MD
University of Vermont
Burlington, VT
Disclosures:
• Advisory Board: Merck & Co.; Hillbloom Foundationt
Lawrence Blonde, MD, FACP, MACE
Ochsner Medical Center
New Orleans, LA
Disclosures:
• Consultant: Corcept Therapeutics;
• Gilead Sciences, Inc.;
• Janssen Pharmaceuticals, Inc;
• Lyndra Therapeutics; Merck; Novo Nordisk;
• Salix Pharmaceuticals; Sanofi
Eden M. Miller, DO
Diabetes and Obesity Care
Bend, OR
Disclosures:
• Advisory Board: Abbott; Lilly USA; Novo Nordisk; Boehringer Ingelheim; Merck; Bayer; Pendulum
Anne L. Peters, MD
University of Southern California
Los Angeles, CA
Disclosures:
• Advisory Board: Abbott Diabetes Care; Astra Zeneca; Lilly; Medscape; Novo Nordisk; Zealand; Vertex
Leonard R. Bertheau, DO
Adventist Health
Portland, OR
Disclosures:
• Speaker: Medtronic
Davida F. Kruger, MSN, APN-BC,BC-ADM
Henry Ford Health System
Detroit, MI
Disclosures:
• Speaker: Novo-Nordisk; Eli Lilly; Abbott Diabetes; Dexcom; Xeris; AstraZeneca; Sanofi
• Advisor: Novo-Nordisk; Eli Lilly; Abbott Diabetes; Sanofi
• Stock Options: Pendulum
• Research Funding: Novo Nordisk; Dexcom; Abbott Diabetes
Robert S. Gotfried, DO, FAAFP
Ohio State University Wexner Medical Center
Columbus, OH
No disclosures
Mark E. Molitch, MD
Northwestern University Feinberg School of Medicine
Chicago, IL
Disclosures:
• Research Funding: Bayer; Novartis
• Consultant: Janssen; Merck; PfizerAccreditation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the American College of Osteopathic Internists. The Endocrine Society is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Category 1 Credit
The American College of Osteopathic Internists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ACOI designates this course for a maximum of 15.00 AMA PRA Category 1™ Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field. Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.AOA Category 1-A Credit
The American College of Osteopathic Internists (ACOI) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOI designates this program for a maximum number of 15.00 AOA Category 1-A credits and will report CME with the extent of the physician’s participation in this activity. This program is sponsored by ACOI for educational purposes only.
Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 15.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For questions about content or obtaining CME credit, please contact the ACOI at education@acoi.org.
-
Register
- Non-member - $550
- Member - $450
- Resident/Fellow - $350
- Student - Free!
- More Information
-
Contains 8 Product(s)
CME Available: 6.0 AOA Category 1-A credits 6.0 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. Recall the 12 recommendations for clinicians who are prescribing opioids from the CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, 2022. Explain strategies to facilitate safe integration of opioid analgesics into treatment plans with considerations for consistent patient education. Detail strategies to facilitate tapering of opioids following evidence-based practices. Characterize key clinical presentations of patients at risk for opioid disorder or who may be inappropriately using opioids. Review strategies for implementing OMT into treatment regimens.
The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.
- Recall the 12 recommendations for clinicians who are prescribing opioids from the CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, 2022.
- Explain strategies to facilitate safe integration of opioid analgesics into treatment plans with considerations for consistent patient education.
- Detail strategies to facilitate tapering of opioids following evidence-based practices.
- Characterize key clinical presentations of patients at risk for opioid disorder or who may be inappropriately using opioids.
- Review strategies for implementing OMT into treatment regimens.
There are 8 courses contained within this series, which will be released on a rolling basis from October 2023 through March 2024.
- I. The Etiopathogenesis and Basics of Pain
- II. Assessment and Measurement of Pain in Patients
- III. Treatment Planning
- IV. Non-Pharmacologic Approaches to Pain Management: OMT
- V. Other Non-Pharmacologic Approaches to Pain Management
- VI. Pharmacologic Approaches to Pain Management
- VII. Managing Patients on Opioids
- VIII. Opioid Use Disorder (OUD)
Disclosure Statements
ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series.
CME Credit and Designation Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.0 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program.
Support Acknowledgement
The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Disclaimer
ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.
DEA MATE Requirements
As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Contains 5 Component(s), Includes Credits
This course covers the Other Non-Pharmacologic Approaches to Pain Management as a part of the collaborative series, "De-Stress Pain Management: Rethinking Opioid and Non-Opioid Therapies," by the American College of Family Physicians and the American College of Osteopathic Internists. This series is aligned with the FDA's Opioid Analgesic REMS Education Blueprint, that will allow you to complete the education at your own pace. Learning Objectives: • Review the historical background of non-pharmacologic approaches. • Interpret knowledge of the various types of physical therapy. • Comprehend pain psychology with consideration of psychological interventions. • Understand the field of implantable devices and surgical procedures with a focus on their applications. CME Credit Available: .75 AOA Category 1-A credits .75 AMA PRA Category 1 Credits™
In this module you will be learning about other non-pharmacologic approaches to pain management that include physical therapy, pain psychology, and implantable devices/surgical procedures, along with many resources to provide you with an opportunity to expand your knowledge even further.
CME Credit Available:
.75 AOA Category 1-A credits
.75 AMA PRA Category 1 Credits™
Review and Release Date:
This activity is valid from January 15, 2024, until January 15, 2027.
Annette T. Carron, DO, MACOI
Medical Director
Seasons Hospice Michigan
Medical Director, Seasons Hospice Michigan
Attending Physician Geriatrics and Palliative Care, Henry Ford Macomb Hospital
Clinical Professor of Medicine
Michigan State University College of Osteopathic Medicine Clinton Township, MIDr. Annette T. Carron, DO, FACOI has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Register
-
Contains 4 Component(s), Includes Credits
This course covers the Non-Pharmacologic Approaches to Pain Management: OMT as a part of the collaborative series, "De-Stress Pain Management: Rethinking Opioid and Non-Opioid Therapies," by the American College of Family Physicians and the American College of Osteopathic Internists. This series is aligned with the FDA's Opioid Analgesic REMS Education Blueprint, that will allow you to complete the education at your own pace. Learning Objectives: • Outline the history of osteopathic medicine. • Summarize the tenets of osteopathic medicine and guiding principles, and osteopathic manipulative treatment (OMT). • Identify the most common OMT techniques used today, along with those that help patients with OUD withdrawal symptoms. • Analyze various evidence-based studies and their results with specific regard to managing pain through OMT techniques. • Develop a provider checklist for assessing patient boundaries and comfort when taking a patient's trauma history before administering OMT practices. CME Credit Available: .75 AOA Category 1-A credits .75 AMA PRA Category 1 Credits™
This module provides some background on osteopathic principles and osteopathic manipulative treatments (OMT), how OMT can help patients suffering from OUD, and what various evidence-based studies have found in the efficacy of OMT treatments for pain management, along with many resources to provide you with an opportunity to expand your knowledge even further.
CME Credit Available:
.75 AOA Category 1-A credits
.75 AMA PRA Category 1 Credits™
Review and Release Date:
This activity is valid from January 15, 2024, until January 15, 2027.
Dr. Melinda Ford, FACOFP
American College of Osteopathic Family Physicians
Dr. Melinda Ford, FACOFP dist. is an assistant professor at the Ohio University Heritage College of Osteopathic Medicine and also works for OhioHealth Physician Group Heritage College as a family medicine and addiction physician. Dr. Ford is board certified in family practice and osteopathic manipulative medicine with a certificate of qualification in addiction medicine. She has made numerous presentations and contributions in the area of addiction treatment, and currently serves as Chair of the board for the Ohio Professional's Health Program- Ohio's confidential monitoring program for impaired health professionals.
Dr. Melinda Ford, FACOFP has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Register
-
Contains 4 Component(s), Includes Credits
This course covers Treatment Planning as a part of the collaborative series, "De-Stress Pain Management: Rethinking Opioid and Non-Opioid Therapies," by the American College of Family Physicians and the American College of Osteopathic Internists. This series is aligned with the FDA's Opioid Analgesic REMS Education Blueprint, that will allow you to complete the education at your own pace. Learning Objectives: • Classify various levels of challenges associated with pain management. • Summarize the updated CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, along with the recommendations categories and evidence types. • Develop treatment goals, which will include a multidisciplinary care team, to maximize patient outcomes. • Outline ways to reduce the chronic use of opioids in pain management. • Analyze the different considerations that should be made when prescribing opioids to patients, including but not limited to, a patient's medical history. • Identify ongoing disparities and barriers to care access some patients encounter when seeking pain treatment. CME Credit Available: .75 AOA Category 1-A credits .75 AMA PRA Category 1 Credits™
In this module, hear an overview of the key components of an effective treatment plan, including the most recent CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, and discuss how to develop treatment goals. Also included is an introduction to reducing chronic use of opioids, considerations for taking a patient-centric approach to pain management and the impact of social determinants of health on access to pain treatment.
CME Credit Available:
.75 AOA Category 1-A credits
.75 AMA PRA Category 1 Credits™
Review and Release Date:
This activity is valid from November 30, 2023 until November 30, 2026.
Dr. Jeff Cashman DO, MS, FACOFP
American College of Osteopathic Family Physicians
Dr. Jeff Cashman DO, MS, FACOFP earned his Bachelor of Science degree in Industrial Engineering from Clemson University (2001), a master’s degree in Epidemiology from the Medical University of South Carolina (2006) and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine-Georgia Campus (2010). He completed his family medicine residency at AnMed Health Family medicine residency in Anderson, SC in 2013.
Dr. Cashman currently serves as the Associate Dean for Pre-Clinical Medical Education at the Edward Via College of Osteopathic Medicine – Carolinas Campus; previously serving as the Associate Dean of OMS-IV and Graduate Medical Education and Discipline Chair of Family Medicine. As well, he serves as a preceptor at the Spartanburg Regional Family Medicine Residency and is the team physician for Spartanburg High School. Prior to starting at VCOM-Carolinas, Dr. Cashman practiced inpatient and outpatient medicine at Mary Black Hospital in Spartanburg, SC.
Dr. Cashman serves as the Speaker of the House of Delegates for the South Carolina Medical Association and was the first Osteopathic President of the Spartanburg County Medical Society. He is involved with the South Carolina Osteopathic Medical Society and previously chaired the SCMA Bioethics Committee and SC Ethics Pandemic Task Force. He is the Leadership Director for VCOM-Carolinas’ HRSA funded Primary Care Champions Fellowship and was named to the SC Rural Physician Board.
Jeff Cashman DO, MS, FACOFP has no disclosures.
-
Register
- Non-member - Free!
- Member - Free!
- Resident/Fellow - Free!
- Student - Free!
- More Information
-
Register
